biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by IMBROKE2on Sep 19, 2012 5:21pm

192 Views

Post# 20387919

RE: Short position...

If you are looking at shorts on this as your basis to claim that this upswing is for real, then you are spreading more manure. The shorts on any junior like this is insignificant and always has been on this stock. And you don't have the latest report for September do you?

I say its not worth $10 because it has no revenues and who is going to pay $400M for a concept?

Bullboard Posts

Buzz on the Bullboards: Stocks to watch in volatile times.